Mamta Bishnoi
Department of Pharmacy, School of Medical and Allied Science, Galgotias University, Greater Noida, Uttar Pradesh, India-203201

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

QbD-based formulation, development and characterization of methotrexate-loaded nanoemulgel for transdermal administration in rheumatoid arthritis: preclinical studies Neha Gupta; Mamta Bishnoi; Shaik Abdul Rahaman
Journal of Applied Pharmaceutical Research Vol. 14 No. 5 (2026)
Publisher : Creative Pharma Assent

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69857/joapr.v14i5.2784

Abstract

Background: Rheumatoid arthritis is an autoimmune inflammatory disease with a chronic relapsing course, and usually lifelong treatment is necessary. Methotrexate, the first-line drug, has poor bioavailability and systemic toxicity after conventional routes of administration. Methodology: They were characterized for particle size, polydispersity index, zeta potential, entrapment efficiency, and percentage transmittance prior to incorporation into Carbopol Ultrez 10 NF gel. MTX-NEG was characterized for physicochemical profiles, in vitro drug release, ex vivo permeation, and pharmacodynamic efficacy in carrageenan-induced paw edema and formaldehyde-induced arthritis models. Result and discussion: The optimized MTX-loaded nanoemulsion showed droplet size of 124.31±0.69 nm, PDI of 0.164±0.01, zeta potential of -28.6±3.9 mV, entrapment efficiency of 85.46±1.24%, and transmittance factor of 98.63±0.95 % which have demonstrated the stability as well as homogeneity of formulations indicated good formulation characteristics for long duration study with distinct advantages over conventional carriers packaged inside micellar aggregates in aqueous. Results: Suitable topical pH, viscosity, and spreadability were achieved with MTX-NEG. In vitro release studies exhibited prolongation of drug release (82.35±0.97% over 48 h) as compared to conventional gel formulations. With ex vivo studies, membrane permeation and skin retention were confirmed. The pharmacodynamic study showed that nanocarriers could significantly inhibit (p < 0.05) paw edema and joint swelling compared to both conventional gel formulations and marketed gels. Conclusion: Physicochemical properties, prolonged drug release, increased membrane permeation, and anti-inflammatory and anti-arthritic efficacy. This nano-mulgel system has shown potential as a topical delivery system for rheumatoid arthritis management.